Changes in Hong Kong stocks | Liangqing Holdings (03774)) rose more than 14% The company's strategic focus anchors “AI+ high-end biotech skincare”

The Zhitong Finance App learned that Liangqing Holdings (03774)) rose by more than 14%. As of press release, it had risen 12.95% to HK$18.4, with a turnover of HK$9.664,800.

According to news, at the end of June this year, Liangqing Holdings officially switched its listing from the GEM to the main board of the Hong Kong Stock Exchange, which is expected to improve the liquidity of stock trading and provide greater flexibility for the company's long-term development. According to reports, Liangqing Holdings is a local medical aesthetic service provider in Hong Kong. Up to now, the company has operated 16 medical aesthetic centers. It is worth mentioning that recently, Perface, a medical beauty brand owned by Liangqing Holdings, won the HydraFacial™ “Best Service Provider” award in the Asia-Pacific region, and was once again certified for its No. 1 sales strength in Hong Kong.

Facing the future, Liangqing Holdings is anchoring its strategic focus on the emerging circuit of “AI+ high-end biotech skincare”. In October 2025, the company established a joint venture with partners such as a Japanese pharmaceutical company and a Singaporean commercial biotech company to focus on the development and sale of anti-aging products and solutions. Up to now, the joint venture has launched the precise anti-aging brand “Skin Source Innovation”, which is committed to providing customers with a comprehensive anti-aging solution from the inside out.